Jump to main content
Jump to site search

Issue 13, 2019
Previous Article Next Article

Multi-screening of β-lactam antibiotics for β-lactamase resistance by means of a paper-based analytical device with a 4-(2-pyridylazo)resorcinol (PAR)–Hg2+ complex

Author affiliations

Abstract

β-Lactam antibiotics are widely used for the treatment of bacterial infections; however, an increase in the number of antibiotic-resistant bacteria, which produce β-lactamases that inactivate β-lactam antibiotics, can lead to serious untreatable diseases. Thus, proper prescribing of antibiotics and the development of new antimicrobial agents with strong resistance to hydrolysis by β-lactamases can be a solution to reduce antibiotic resistance and treat various bacterial infections. Accordingly, simple and rapid methods for the screening of antibiotics that show β-lactamase resistance are required. Therefore, we designed a multi-channel microfluidic paper-based analytical device (μPAD) for colorimetric screening of β-lactam antibiotics for β-lactamase resistance; the μPAD, created by modifying paper with self-assembling organosilane and a 4-(2-pyridylazo)resorcinol (PAR)–Hg2+ complex, can screen β-lactam antibiotics for hydrolytic resistance to multiple β-lactamases at once. To demonstrate its suitability for this task, we confirmed the resistance of already studied β-lactam antibiotics—penicillin G, cloxacillin, and ceftazidime—toward different classes of β-lactamases (penicillinase, TEM-1, and CTX-M-1) using the μPAD. Based on ligand exchange between hydrolyzed β-lactam antibiotics and PAR in the PAR–Hg2+ complex, colorimetric detection of the relative susceptibilities of β-lactam antibiotics to a β-lactamase is possible even with the naked eye in only 10 minutes. The portable and equipment-free μPAD allows for simple multi-screening of diverse classes of β-lactam antibiotics for β-lactamase resistance.

Graphical abstract: Multi-screening of β-lactam antibiotics for β-lactamase resistance by means of a paper-based analytical device with a 4-(2-pyridylazo)resorcinol (PAR)–Hg2+ complex

Back to tab navigation

Supplementary files

Publication details

The article was received on 30 Jan 2019, accepted on 12 Feb 2019 and first published on 15 Feb 2019


Article type: Paper
DOI: 10.1039/C9AY00223E
Anal. Methods, 2019,11, 1729-1734

  •   Request permissions

    Multi-screening of β-lactam antibiotics for β-lactamase resistance by means of a paper-based analytical device with a 4-(2-pyridylazo)resorcinol (PAR)–Hg2+ complex

    S. Lee, M. S. Eom and M. S. Han, Anal. Methods, 2019, 11, 1729
    DOI: 10.1039/C9AY00223E

Search articles by author

Spotlight

Advertisements